Serial No. 115-136: Examining the Reauthorization of the Pandemic and All-Hazards Preparedness Act, Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, Second Session, June 6, 2018 [open pdf - 10MB]
This is the June 6, 2018 hearing on "Examining the Reauthorization of the Pandemic and All-Hazards Preparedness Act," held before the Subcommittee on Health of the Committee on Energy and Commerce. From the opening statement of Hon. Gene Green: "Events in recent years including natural disasters, cyber terrorism, influenza epidemic has posed a threat to our public health systems and our national security. PAHPA [Pandemic and All Hazards Preparedness Act] provides a framework that allows us to address in a coordinated way various threats both natural and manmade. [...] I hope our committee will look at the very real threat that antimicrobial resistance poses. Antibiotics and antimicrobial agents have been used for the last 70 years to treat patients who have infectious diseases. These drugs greatly reduce illnesses and death from infectious diseases. However, these drugs are being used so widely and for so long that the infectious organisms that the antibiotics are designed to kill have adapted to them and make the drugs less effective. [...] Through the reauthorization of PAHPA we need to ensure that the proper incentives are in place that will lead to investment in the development of new antibiotics and antimicrobial agents." Statements, letters, and materials submitted for the record include those of the following: Robert Kadlec, Stephen Redd, Anna Abram, Umair Shah, Michelle Berrey, and Erik Decker.
Serial No. 115-136
Government Publishing Office: http://www.gpo.gov/